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More than amilionworkers are at riskformethylene chloride exposure. Aerosol sprays andpaint
stripping may also cause significant nonoccupational exposures. After methylene chloride inhala-
tion, significant amounts of carbon monoxide are formed in vivo as a metbolic by-product.
Poisoning predominantly affects the central nervous system and results from both carboxyhemo-
globin formation and direct solvent-related narcosis. In this report, we describe a case ofmethyl-
ene chloride intoxication probably complicated by exogenous carbon monoxide exosure. The
worker's presentation of intermittent headaches was consistent with both methylene chloride
intoxication and carbon monoxide poisoning. The exposures andsymptoms werecorroboratedby
elevated carboxyemoglobin saturations and aworkplace inspection that documented significant
exposures to both methylene chloride and carbon monoxide. When both carbon monoxide and
methylene chloride are inhaled, additional carboxyhemoglobin formation is expected. Preventive
efforts should indude education, air monitoring, and periodic carboyhemoglobin determina-
tions. Methylene chloride should never be used in endosed or poorlyventilated areas because of
the well-documented dangers of loss ofconsciousness and death. Key work carbon monoxide,
carboxyhemoglobin, methylene chloride, occupational exposure. Environ Health Perspect
107:769-772 (1999). [Online 10August 1999]
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Case Presentation
A 26-year-old male presented in February
1996 with the complaint of persistent
headaches for 1 month. The patient had
two evaluations in an emergency department
and a subsequent consultation with a
headache specialist whose working diagnosis
was that the headaches were stress related
with possible exacerbation by fumes at the
patient's workplace.
The patient had a history of occasional
headaches since adolescence; during the past
4 months, his symptoms had increased in
intensity and frequency and were no longer
relieved by over-the-counter medication. The
headaches were retroorbital with radiation to
the backofthe head andwere associated with
sensitivity to bright lights and noise and
occasionally with nausea. He denied other
neurologic symptoms.
He had worked as a carpenter in a lami-
nated product manufacturing company for
the previous 6 months. He worked with 10
other cabinet workers in a building approxi-
mately 50 ft x 200 ft in size. There was an
unenclosed spray booth with some local
exhaust ventilation and with gas-powered
heating fans hanging from the ceilings. The
doors were kept closed during winter months
to prevent heat loss.
The patient's job tasks at the time of
presentation involved working with lacquer
thinner to clean cabinet surfaces and spray-
ing laminating materials over cabinet sur-
faces. Neither he nor the other workers used
any type of personal protective equipment
while working with these chemicals. He
reported that he and several ofhis co-work-
ers had recently noticed drying and cracking
of the skin on their hands from touching
lacquer thinner. Some of the other workers
had also complained ofheadaches, but their
headaches were not as severe as his.
The patient brought material safety data
sheets for two compounds he often used: a
clear, nonflammable spray contact cement
that contained 70% methylene chloride
(MeCI2), toluene, and methyl ethyl ketone,
and a lacquer thinner that contained toluene,
isopropyl alcohol, ethyl acetate, isobutyl alco-
hol, and isobutyl acetate.
The patient's environmental history was
noncontributory. The patient was a non-
smoker, reported drinking one beer perweek,
and denied any illicit drug use. His current
medications included amitriptyline (50
mg/day) and diphenhydramine (150 mg
every night at bedtime). The patient's signifi-
cant past medical history revealed depression
and a motor vehicle accident with resultant
whiplash and back injuries 18 months before
presentation. He denied any headaches after
the accident. At 8 years ofage, the patienthad
also sustained a basilar skull fracture from a
bicycle accident and had some residual hear-
ing loss on the left side. His family history
was significant only in that his mother suffers
from migraineheadaches.
On physical examination, the patient
appeared well nourished, well hydrated, and
in no apparent distress. Vital signs included a
blood pressure of 110/72 and unremarkable
pulse, respirations, and temperature. The
patient's skin on both hands showed marked
dermal thickening and very dry skin with fis-
sures and cracking. A fundoscopic exam was
unremarkable. No paranasal sinus tenderness
was noted. A neurological exam revealed no
deficits, and the rest ofthe physical examina-
tionwas unremarkable.
Initial lab data revealed a normal com-
plete blood count, normal liver function
tests, and a blood COHb saturation of2.8%
(normal < 3% for nonsmokers).
The patient was instructed to have his
primary care physician check his COHb sat-
uration after a work shift, particularly when
he was symptomatic, in order to exclude car-
bon monoxide intoxication from MeCl2
exposure. On the following day, although the
doors of the workplace were open, he had a
mild headache and his post-shift COHb sat-
uration was 6.4%. The consultants, however,
were not notified at this time.
Four days later, the doors ofthe patient's
workplace were closed for the day and he
reported poor ventilation. He became
extremely symptomatic, including nausea
and vomiting, and left work early for his
primary care physician's office. He was
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reported to have a COHb saturation of21%
approximately 35 min after leaving his work
site. He subsequently received normobaric
oxygen therapy at the affiliated emergency
department. A follow-up COHb saturation
the next day was normal, and the consul-
tants were notified at this time.
Based on the patient's elevated COHb
saturations and the presence of the MeCI2-
containing product, the Commonwealth of
Massachusetts Division of Occupational
Hygiene (DOH) and the local health depart-
ment were contacted immediately. An
immediate inspection was conducted by the
DOH and local health and fire departments.
The major findings were the use ofthe prod-
uct containing 70% MeCI2 and areasamples
with MeCI2 levels of300-500 ppm and CO
levels of28 ppm. Based on this information,
the company immediately substituted a
water-based process for the one previously
utilizing MeCI2.
A second inspection was conducted 8
days later to evaluate the new process. Repeat
air sampling showed unremarkable levels of
solvents in both area and personal breathing
zonesamples and apeak CO measurement of
8 ppm. Additionally, apropane-powered fork
lift inside the plant was considered a potential
sourceofcarbon monoxide exposure.
Discussion
MeCI2, also known as dichloromethane
(DCM), methylene dichloride, and methyl-
ene bichloride, is a volatile, dear, and color-
less lipophilic solvent (1,2). It has a mild,
sweet odor with an olfactory threshold of
100-300 ppm (1).
Human exposure is mainly due to
inhalation. The liver is the primary site of
metabolism, where significant amounts are
biotransformed to carbon monoxide (CO)
(3). The primary target organ ofMeCI2 toxi-
city is the central nervous system (1,4,5).
These effects result from both direct solvent-
related narcosis and endogenous production
of CO with subsequent carboxyhemoglobin
(COHb) formation (4,61-). IfCO is inhaled
from either the environment or from tobacco
smoke, this exogenous CO exposure leads to
additional COHb formation in an additive
fashion (9,10). The most serious manifesta-
tions ofMeCI2 poisoning are unconscious-
ness and death, and a number of fatalities
have been reported in the literature
(5,8,9,11,12). Most ofthese cases were asso-
ciated with paint or furniture stripping
and/orendosed spaces.
Once MeCI2 is inhaled, the major sites
of distribution are the liver, brain, and fat
(1). Factors affecting the resulting body bur-
den are the ambient MeCI2 concentration,
duration of exposure, route of exposure,
physical activity, and the amount ofbody fat
(1,6,9,13). In addition to the liver, metabo-
lism may also occur in the lungs and kidneys
(1). Metabolism occurs via two basic routes,
a mixed-function oxidase (MFO) pathway
and a glutathione transferase (GST) pathway
(2.6). The MFO pathway is predominant
and converts MeCI2 to CO, but is saturable
at high exposure levels (2,6). Both the direct
neurologic effects ofMeCl2 and CO toxicity
appear to contribute to the adverse effects of
MeCI2 exposure (4,6-8,14). During acute
and intense exposures to MeCI2, which usu-
ally occur in poorly ventilated areas, the
direct solvent-related narcotic effects may
play a greater initial role in central nervous
system depression (5,7,8,11,14). For exam-
ple, Rioux and Myers (4) reported two
workers who were found unconscious in a
semienclosed area with high levels ofMeCl2
fumes. Despite prior loss of consciousness,
their initial presenting COHb saturations
were only 5 and 7%.
The metabolic formation of CO and
subsequent COHb formation may continue
for several hours after the cessation ofMeCl2
exposure, as fat and other tissues continue to
release accumulated solvent (4,9,15,16).
Endogenous CO production at a rate greater
than the rate of excretion accounts for a
gradual increase in the COHb level in blood
(16). Rioux and Myers (4) reported that,
despite treatment with hyperbaric oxygen,
the COHb levels ofboth men continued to
rise after they were removed from exposure
due to theirhigh bodyburdens ofMeCI2.
The dose response demonstrates a linear
relationship between MeCI2 exposure (for
both duration of exposure and intensity of
exposure) and COHb levels (9,10,16,17).
This is illustrated in Figure 1. In smokers, the
dose response is shifted upward by the
additional CO inhalation (10). At approxi-
mately 180 ppm MeCl2, the rate ofincrease
is 0.5% COHb/hr (16). Therefore, during
nonoverwhelming and longer exposures to
MeCI2, carboxyhemoglobinemia resulting
from hepatic conversion may be responsible
for most of the observed toxicity. Other
dihalomethanes, induding dibromomethane,
diiodomethane, and bromochloromethane,
have also been documented to undergo in
vivobiotransformation to CO (6).
This case study describes MeCI2 intox-
ication resulting from an industrial process.
The workers' symptoms of intermittent
headaches, nausea, and vomiting and elevat-
ed COHb saturations are consistent with
both MeCI2 intoxication (1,5,17) and CO
poisoning (18,19). The markeddegree ofcar-
boxyhemoglobinemia (> 20%) withoutlossof
consciousness and the significant ambient
CO concentration in the workplace suggest
that our patient's situation was probably
complicated by exogenous CO exposure.
Sources ofexogenous CO in the present case
couldhave been thegas-powered heating fans
and/or the propane-powered forklift. The
operation of propane-fueled forklifts in
unventilated areas is a documented cause of
CO poisoning (20).
When ambient CO exposure and MeCl2
exposure occur simultaneously, the exoge-
nous CO exposure results in COHb forma-
tion in addition to that generated by hepatic
transformation ofMeCI2 to CO (1,10). The
conditions found during the inspection of
the patient's workplace were probably similar
to those that produced the poisoning
episode. The inspection documented spot
exposures via area samples of 300-500 ppm
MeCl2 and 28 ppm CO. Ratney et al. (16)
reported that 8-hr exposure to MeCI2 at
approximately 180 ppm resulted in COHb
saturations of 6-12% in nonsmokers.
Shusterman et al. (17) found COHb satura-
tions of 10-11% and similar presenting
symptoms in a worker after 6.5-7.5 hr of
exposure to approximately 350 ppm MeCI2.
Eight hour exposure at 500 ppm MeCI2
would be expected to produce COHb satura-
tions in excess of 12% (17). Exposures to
exogenous CO in nonsmokers at 25 and 50
ppm are expected to produce COHb satura-
tions of 3-4% and 6-8%, respectively (21).
Thus, the combined exposures observed dur-
ing the inspection ofthe patient's workplace
might have been expected to produce COHb
saturations of approximately 16%, which is
within the order of magnitude of the 21%
reported in ourpatient.
Ourpatient's actual exposures could have
been even higher iftheMeCl2 concentrations
had been higher in his breathing zone during
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Figure 1. Methylene chloride dose response
between carboxyhemoglobin (COHb)formation and
both the duration and intensity of exposure to
MeCI2. The measured COHb saturation is shown as
a function ofthe exposure duration and the MeCI2
concentration in parts per million. Data from
Stewart and Hake (9), Soden etal. (10), DiVincenzo
and Kaplan (13), and Shusterman etal. (17).
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the spray operation (versus areas samples), if
ambient MeCl2 and CO concentrations had
been higher due to decreased ventilation,
and if there had been increased absorption
due to physical activity. Absorption can also
result from skin contact, but at a lower rate
compared to other routes because of rapid
evaporation (1). Because ofour patient's sol-
vent-related dermatitis, facilitated skin
absorption could have made a small contri-
bution to exposure in his case (22).
Appropriate treatment ofMeCl2 intoxi-
cation includes removal from exposure, sup-
plemental 100% oxygen, and supportive
measures as indicated. As absorbed MeCl2 is
depleted, CO excretion continues and
COHb saturations will eventually begin to
decrease. After exposure has been terminated,
however, MeCl2 stores continue to be con-
verted to CO. Therefore, the decay of
MeCl2-induced COHb is slower than that of
COHb derived from ambient inhaled CO.
The elimination half-life of MeCl2-derived
COHb is 13 hr when breathing room air
(16) and has been estimated to fall to approx-
imately 6 hr with the administration of
100% normobaric oxygen (4). These values
compare with elimination half-lives of
COHb derived from exogenous CO inhala-
tion ofapproximately 4 hr for room air, 60
min for 100% normobaric oxygen, and < 30
min for 100% hyperbaric oxygen at 3 atmos-
pheres (18). Therefore, MeCl2-induced car-
boxyhemoglobinemia may require prolonged
treatment (4).
Other central nervous system effects of
MeCI2 exposure include impaired visual,
auditory, and psychomotor performance (2).
MeCI2 may also be an ocular and respiratory
irritant (17,23,24). Snyder et al. (25,26)
reported pulmonary edema in two victims,
with subsequent &e novo asthma developing
in one of the two cases; however, the two
individuals were also exposed to phosgene.
Direct contact with the eyes may result in
corneal burns (5), dermal exposure maycause
erythema and burning (2X), and skin immer-
sion mayproduce chemical burns (5).
High MeCI2 exposures have anecdotally
been linked to ischemic electrocardiographic
changes (14) and myocardial infarction (9).
Studies demonstrating decreased exercise
times to angina or increased arrhymias in
coronary heart disease patients with COHb
saturations of 2-6% (28-31) have raised
concern that MeCl2 exposures producing
similar COHbs could also produce cardiac
disturbances in susceptible individuals (32).
However, epidemiologic studies ofworkers
exposed to several hundred parts per million
MeCl2 have not documented excess mortali-
ty due to ischemic heart disease (33-35) or
increased cardiac symptoms (36).
Human epidemiologic studies have either
failed to show evidence for excess cancer
deaths in MeCl2-exposed workers or to
demonstrate inconsistent associations (2).
Based on all ofthe evidence, the International
Agency for Research on Cancer (37) considers
MeCl2 to be possiblycarcinogenic to humans,
whereas the U.S. Environmental Protection
Agency has dassified it as a probable human
carcinogen (2).
MeCl2 exposure is usually occupational
in nature. Ithas awidevariety ofapplications
including deaning, degreasing, paintandvar-
nish thinning and removal, manufacturing of
synthetic fibers and plastics, use as an aerosol
propellant, use as a blowing agent for foods
and spices, use as a grain fumigant and low-
pressure refrigerant, and use in certain paints,
inks, adhesives, pharmaceuticals, and photo-
graphic films (1,6). It has been estimated that
more than a million workers are at risk for
potential exposure (1).
Environmental and household exposures
arealsoprimarilydueto inhalation (2). MeCl2
is found in a number ofcommon household
products such as flame retardants, hair sprays,
antiperspirants, air fresheners, and spray
paints; themostsignificantexposuresprobably
result from aerosol sprays and from paint,
varnish, orfurniturestripping (1).
Conclusion
Adverse health effects due to MeCl2 can be
avoided by substituting safer products or
processes for those using MeCl2, such as the
alternative process adopted by the manufac-
turer in this case. When MeCl2 is used,
adequate ventilation is essential to keep expo-
sures at low levels. MeCl2 should never be
used in enclosed or poorly ventilated areas
because of the unacceptable risk of loss of
consciousness and death (4,5,8,11). It is
important to educate those using MeCI2-con-
taining products about safety hazards and
monitoring ofairborne concentrations. Table
1 summarizes regulatory data for MeCl2 and
CO and expected biologic exposures to
COHb. Ambient exposurestandards may not
adequately protect all susceptible individuals
such as those with significant underlying
coronary heart disease. In addition, these
guidelines are not designed to account for
additional CO exposures from ambient air
and/or concomitant smoking. Therefore,
these measures should be supplemented by
monitoring exposed workers for COHb.
COHb saturations > 3% should be consid-
eredelevated in nonsmokers (39).
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